Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Stephen Rusckowski, Daniel Von Hoff, Nikko Khazana, Kevin Davies


Stephen Rusckowski has been named chairman of the American Clinical Laboratory Association's board of directors.

Rusckowski has served as Quest Diagnostics' president and CEO since May 2012. Before joining Quest Diagnostics, he was CEO of Philips Healthcare.

The Hope Funds for Cancer Research has awarded Daniel Von Hoff one of its five annual awards of excellence in medicine.

Von Hoff is physician-in-chief and distinguished professor at the Translational Genomics Research Institute and chief scientific officer at Scottsdale Healthcare's Virginia G. Piper Cancer Center.

CompanionDx Reference Lab has appointed Nikko Khazana senior vice president of sales. CompanionDx is a CLIA-certified laboratory specializing in pharmacogenomics, cancer companion diagnostics, targeted next-generation sequencing, and epigenomics testing.

Khazana joins the company from Cardinal Health Specialty, where he led the strategy and growth of the group purchasing organization and the build-out of its urology division. He has also held various executive management positions in sales, marketing, strategy and operations during the past 20 years within the pharmaceutical-biotech industry.

Pathway Genomics said this week that Kevin Davies has joined its scientific advisory board.

Davies is founding editor of Nature Genetics, a VP with the American Chemical Society, and is publisher of Chemical & Engineering News. He was the founding editor of Bio-IT World and an editor-in-chief at Cell Press.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.